Formation Bio is an AI-native drug developer, bringing new medicines to patients faster and more efficiently. The company licenses or acquires clinical-stage drugs and advances them in-house.
Products & media
Formation Bio 2026 Citizen Builder Bootcamp
A preclinical oral small-molecule miR-124 inducer being developed for autoimmune disease and inflammatory conditions.
A Phase 1 central-nervous-system-penetrant TYK2 inhibitor being developed for inflammatory diseases.
A Phase 2 recombinant human fibroblast growth factor 18 biologic being developed as a potential disease-modifying treatment for knee osteoarthritis.
Team
Jobs
See all jobs for Formation Bio here.
Funding
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Data current as of June 26, 2024
Leads
Participating Firms
Angels
$372M
$156M$1B valuation
Backed by
Sequoia Capital
Thrive Capital
S32